The cyclopentone prostaglandin 15-deoxy-Δ12,14 prostaglandin J2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells

Journal of Neuroimmunology

Volumn 115, Issue 1-2, 2001, Pages 28-35

  Drew, Paul D ^a   Chavis, Janet A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

15 Deoxy 12,14 prostaglandin J2; IL 12; Microglia; Nitric oxide; TNF

Indexed keywords

15 DEOXY DELTA PROSTAGLANDIN J2; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL SECRETION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; STIMULATION; T LYMPHOCYTE; TH1 CELL;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN D2; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035795009     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00267-3     Document Type: Article

References (48)

1. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases
2. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype
3. + T cells via CD40 ligand
4. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner
5. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
6. Interleukin-12 production by human polymorphonuclear leukocytes
7. 12,14-prostaglandin J2 in activated murine macrophages
8. Cholesterol oxides induce programmed cell death in microglial cells
9. Inducible nitric oxide synthase activity in cloned murine microglial cells
10. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
11. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice
12. Regulation of MHC class I and β2-microglobulin gene expression in human neuronal cells: Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes
13. Inducible cyclooxygenase may have anti-inflammatory properties
14. Microglia as mediators of inflammatory and neurodegenerative diseases
15. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor
16. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
17. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
18. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
19. + T cells in the pathogenesis of organ-specific autoimmune diseases
20. The clinical potential of cyclooxygerase-2-specific inhibitors
21. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1
22. Immunological aspects of demyelinating diseases
23. Cellular signaling roles of TGF beta, TNF alpha, and beta APP in brain injury responses and Alzheimer's disease
24. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
25. Inflammation of the brain in Alzheimer's disease: Implications for therapy
26. The role of tumor necrosis factor, interleukin 6, interferon-gamma, and inducible nitric oxide synthase in the development and pathology of the nervous system
27. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology
28. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis
29. Microglia and macrophagese
30. 12,14-prostaglandin J2
31. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+2-T lymphocytes
32. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity
33. The Norton Lecture: A review of the oligodendrocyte in the multiple sclerosis lesion
34. The peroxisome proliferator activated receptor-γ is a negative regulator of macrophage activation
35. Anti-inflammatory cyclopentone prostaglandins are direct inhibitors of IκB kinase
36. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
37. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis
38. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
39. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination
40. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta
41. PPARγ in monocytes: Less pain, any gain?
42. Indictment of microglia as the villain in multiple sclerosis
43. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response
44. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
45. Axonal transection in the lesions of multiple sclerosis
46. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions
47. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
48. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase